Global Artificial Coma/Medical Induced Coma Market
Dublin, April 29, 2022 (GLOBE NEWSWIRE) — The report “Global Artificial Coma/Medical Induced Coma Market Opportunity Analysis and Industry Forecast (by Drug Type, Application and Distribution Channel), 2021-2030” has been added to ResearchAndMarkets.com’s offer.
The global artificial coma/medically induced coma market was valued at $640.17 million in 2020 and is expected to reach $868.63 million by 2030, at a CAGR of 3.1%.
An increase in the number of surgical procedures such as cosmetic surgery and brain surgery leads to an increase in the use of drugs such as propofol and barbiturate to induce coma in patients. In addition, a growing geriatric population is contributing significantly to the market growth. An increase in the production of various types of drugs to induce coma is a major driving force behind the global market.
In addition, according to statistics from the American Society of Plastic Surgeons in 2019, approximately 1.8 million cases of cosmetic minimally invasive surgery were performed in the US. The application of anesthetics in general surgery is expected to drive the growth of the market. In addition, the increasing number of emergency surgeries, extensive use of propofol and barbiturate drugs are driving the growth of the market.
The global artificial coma/medically induced coma market is segmented on the basis of drug type, application, distribution channel, and region. The market is divided into propofol and barbiturate by drug type. By application, the market is fragmented into status epilepticus, stroke, traumatic brain injury, brain infections, drug overdose and others. The market is subdivided per distribution channel into hospital pharmacies, drugstores & pharmacies and online providers. Regionally, it is analyzed in North America, Europe, Asia-Pacific and LAMEA.
Rising demand for pain management in the geriatric population
Increase in emergency operations
Increase in drug launches and approvals
Rising cancer prevalence
Some of the key companies operating in the global artificial coma/medically induced coma market are Astrazeneca Plc., B. Braun Melsungen, Baxter Healthcare Corporation, Dr. Reddy’s Laboratories, Fresenius SE & CO., Hikma Pharmaceuticals, Pfizer Inc., Piramal Healthcare, Teva Pharmaceuticals Industries Ltd. and Viatris Inc.
Key Report Benefits:
This report provides a comprehensive analysis of the current and emerging market trends and dynamics in the Global Artificial Coma/Medical Induced Coma Market to identify prevailing opportunities.
This study presents the competitive landscape of the global market to predict the competitive environment in different geographic areas.
Comprehensive analysis of factors driving and restraining market growth is provided.
Region and country analysis is provided to understand market trends and dynamics.
KEY MARKET SEGMENTS
By drug type
Traumatic brain damage
By distribution channel
KEY MARKET PLAYERS
For more information on this report, please visit https://www.researchandmarkets.com/r/agjuc1
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900